Literature DB >> 16388597

A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase.

Elizabeth M Sale1, Conrad P Hodgkinson, Neil P Jones, Graham J Sale.   

Abstract

Protein kinase B appears to play a key role in insulin signaling and in the control of apoptosis, although the precise targets of PKB are incompletely understood. PKB exists as three isoforms (alpha, beta, and gamma) that may have unique as well as common functions within the cell. To facilitate understanding the precise roles of PKB and its isoforms, novel tools of widespread applicability are described. These tools are antisense oligonucleotide probes that enable the specific and potent knock down of endogenous PKB alpha, beta, or gamma isoforms, individually or in various combinations, including concurrent removal of all three isoforms. The probes were applied to dissect the role of PKB in phosphorylating glycogen synthase kinase-3 (GSK-3), a critical mediator in multiple responses, and other potentially key targets. Triple antisense knock down of PKB alpha, beta, and gamma so that total PKB was <6% blocked insulin-stimulated phosphorylation of endogenous GSK-3alpha and GSK-3beta isoforms by 67% and 45%, respectively, showing that GSK-3alpha and GSK-3beta are controlled by endogenous PKB. Each PKB isoform contributed to GSK-3alpha and GSK-3beta phosphorylation, with PKBbeta having the predominant role. Knock down of total PKB incompletely blocked insulin-stimulated phosphorylation of GSK-3alpha and GSK-3beta, and a pathway involving atypical PKCs, zeta/lambda, was shown to contribute to the signal. Triple antisense knock down of PKB alpha, beta, and gamma abrogated the insulin-stimulated phosphorylation of WNK1, ATP citrate lyase, and tuberin. However, antisense-mediated knock down of PKB alpha, beta, and gamma had no effect on insulin-stimulated DNA synthesis in 3T3-L1 adipocytes, indicating that pathways other than PKB mediate this response in these cells. Finally, our PKB antisense strategy provides a method of general usefulness for further dissecting the precise targets and roles of PKB and its isoforms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16388597     DOI: 10.1021/bi050287i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathways.

Authors:  Jun-ichi Hanai; Nathaniel Doro; Atsuo T Sasaki; Susumu Kobayashi; Lewis C Cantley; Pankaj Seth; Vikas P Sukhatme
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

2.  PI3K-Akt1 expression and its significance in liver tissues with chronic fluorosis.

Authors:  Bin Fan; Yanni Yu; Ying Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 3.  A two-way street: reciprocal regulation of metabolism and signalling.

Authors:  Kathryn E Wellen; Craig B Thompson
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-07       Impact factor: 94.444

Review 4.  The WNKs: atypical protein kinases with pleiotropic actions.

Authors:  James A McCormick; David H Ellison
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 5.  Regulation of signaling pathways in hair follicle stem cells.

Authors:  Xiaoxiang Wang; Yinghui Liu; Jia He; Jingru Wang; Xiaodong Chen; Ronghua Yang
Journal:  Burns Trauma       Date:  2022-07-04

Review 6.  Emerging roles for WNK kinases in cancer.

Authors:  Sónia Moniz; Peter Jordan
Journal:  Cell Mol Life Sci       Date:  2010-01-22       Impact factor: 9.261

7.  Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts.

Authors:  Ronald W Matheny; Martin L Adamo
Journal:  Biochem Biophys Res Commun       Date:  2009-09-30       Impact factor: 3.575

8.  A comparative proteome analysis links tyrosine kinase 2 (Tyk2) to the regulation of cellular glucose and lipid metabolism in response to poly(I:C).

Authors:  Tom Grunert; Nicole R Leitner; Martina Marchetti-Deschmann; Ingrid Miller; Barbara Wallner; Marta Radwan; Claus Vogl; Thomas Kolbe; Dagmar Kratky; Manfred Gemeiner; Günter Allmaier; Mathias Müller; Birgit Strobl
Journal:  J Proteomics       Date:  2011-07-23       Impact factor: 4.044

Review 9.  Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications.

Authors:  Shan Jin; Oyungerel Borkhuu; Wuyuntu Bao; Yun-Tian Yang
Journal:  J Clin Med Res       Date:  2016-02-27

Review 10.  WNK pathways in cancer signaling networks.

Authors:  Sachith Gallolu Kankanamalage; Aroon S Karra; Melanie H Cobb
Journal:  Cell Commun Signal       Date:  2018-11-03       Impact factor: 5.712

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.